Hisse Senetlerindeki Sıralama
#13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Ticaret Sensorion SA (ALSEN)
B piyasa değeri ile ALSEN fiyatı
Piyasa Değeri Sensorion SA(ALSEN)
Piyasa Değeri: $94.19M
July 2026 itibarıyla Sensorion SA şirketinin piyasa değeri $94.19M. Bu, verilerimize göre Sensorion SA şirketini dünyanın en değerli 13314th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Sensorion SA piyasa değeri geçmişi (2015 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında ALSEN
| ALSEN’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.055T
|
+5,367,199.62%
|
|
|
|
|
$4.748T
|
+5,041,119.38%
|
|
|
|
|
$4.310T
|
+4,576,070.70%
|
|
|
|
|
$2.875T
|
+3,052,417.88%
|
|
|
|
|
$2.652T
|
+2,815,687.76%
|
